This narrative review synthesizes current evidence on lifestyle, pharmacological, surgical, and multimodal interventions targeting muscle strength, body composition, and functional capacity in HFpEF with sarcopenia and/or obesity. Exercise, particularly concurrent endurance and resistance training protocols, improve ae...
K. Prokopidis, Aniket S. Joshi, Søren Gam et al.· Current Heart Failure Report...· 0 citations
Sarcopenia, characterized by the age-related decline in muscle mass and strength, increases the risk of falls, fractures, disability, and mortality. Type 2 diabetes and obesity frequently coexist with sarcopenia, contributing to the growing clinical challenge of sarcopenic obesity. Incretin-based therapies, including g...
K. Prokopidis, Stefano Cacciatore, Stephen D. Anton et al.· Advances in Therapy· 0 citations
Frailty components, especially weakness and slowness, are significantly associated with mortality and related outcomes, highlighting the urgency of early frailty detection to improve patient prognosis and urging early identification and intervention to enhance patient care and reduce clinical burden.
K. Prokopidis, F. S. Ragusa, Roberta Bonica et al.· Aging Clinical and Experimen...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.